Tensive Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.62M

  • Investors
  • 7

Tensive General Information

Description

Developer vascularized biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's prostheses use porously implantable based on biodegradable synthetic biomaterials and fabricated with internal micro-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling patients to improve their quality of life and avoid recurrent and expensive surgical operations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Corporate Office
  • Viale Ortles 22/4
  • 20139 Milan
  • Italy
+39 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tensive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 19-Dec-2022 $2.62M 00.000 Completed Generating Revenue
3. Grant 31-May-2018 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 20-May-2016 $2.27M $2.27M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view Tensive’s complete valuation and funding history, request access »

Tensive Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer vascularized biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The c
Therapeutic Devices
Milan, Italy
20 As of 2024
00.000
0000000000 00.000

0000 0

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000 00000000
Greenville, SC
0 As of 0000
000.00
0000000000 0

000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
00000000000 0000000
Rio de Janeiro, Brazil
000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tensive Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zylo Therapeutics Venture Capital-Backed Greenville, SC 0 000.00 0000000000 0
Silimed Corporate Backed or Acquired Rio de Janeiro, Brazil 000 000.00 000000000 000.00
Ideal Implant Formerly VC-backed Dallas, TX 00 0000 000000&0 0000
CardioFocus Venture Capital-Backed Marlborough, MA 00 00000 00000000000 00000
Solta Medical Formerly VC-backed Hayward, CA 000 00000 00000000
To view Tensive’s complete competitors history, request access »

Tensive Patents

Tensive Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020471265-A1 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020 000000000
US-20230270918-A1 Three-dimensional implantable matrix with reduced foreign body response Pending 06-Oct-2020 000000000
AU-2020471265-B2 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020 000000000
CA-3197747-A1 Three-dimensional implantable matrix with reduced foreign body response Pending 06-Oct-2020 000000000
EP-4204029-A1 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020 A61L27/56
To view Tensive’s complete patent history, request access »

Tensive Executive Team (7)

Name Title Board Seat
Federico Martello Ph.D Co-Founder, President, Chief Executive Officer & Chief Operating Officer
Alberto Cantaluppi MD Chairman & President
Valentina Morigi Co-Founder, Chief Financial Officer & Board Member
Alessandro Tocchio Ph.D Co-Founder & Chief Strategy Officer
Irini Gerges Ph.D Co-Founder, Chief Technology Officer & Director of Research & Development
You’re viewing 5 of 7 executive team members. Get the full list »

Tensive Board Members (3)

Name Representing Role Since
Alberto Cantaluppi MD Tensive Chairman & President 000 0000
Valentina Morigi Tensive Co-Founder, Chief Financial Officer & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Tensive Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tensive Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
CDP Venture Capital Venture Capital Minority 000 0000 000000 0
EASME - EU Executive Agency for SMEs Corporation Minority 000 0000 000000 0
UniCredit Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Tensive FAQs

  • When was Tensive founded?

    Tensive was founded in 2012.

  • Who is the founder of Tensive?

    Federico Martello Ph.D, Valentina Morigi, Alessandro Tocchio Ph.D, Irini Gerges Ph.D, and Margherita Tamplenizza Ph.D are the founders of Tensive.

  • Who is the CEO of Tensive?

    Federico Martello Ph.D is the CEO of Tensive.

  • Where is Tensive headquartered?

    Tensive is headquartered in Milan, Italy.

  • What is the size of Tensive?

    Tensive has 20 total employees.

  • What industry is Tensive in?

    Tensive’s primary industry is Therapeutic Devices.

  • Is Tensive a private or public company?

    Tensive is a Private company.

  • What is Tensive’s current revenue?

    The current revenue for Tensive is 00000.

  • How much funding has Tensive raised over time?

    Tensive has raised $2.27M.

  • Who are Tensive’s investors?

    European Innovation Council Fund, Horizon 2020 SME Instrument, CDP Venture Capital, EASME - EU Executive Agency for SMEs, and UniCredit are 5 of 7 investors who have invested in Tensive.

  • Who are Tensive’s competitors?

    Zylo Therapeutics, Silimed, Ideal Implant, CardioFocus, and Solta Medical are some of the 6 competitors of Tensive.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »